LAURA DIMENNA: Open Payments
NPI 1619512829 · BARRINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 95 payments from 17 companies in 2025. Trend: 2023 $862 · 2024 $1,570 · 2025 $1,565
Food & beverage: $1,493Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $328 |
| Novartis Pharmaceuticals Corporation | 13 | $175 |
| UCB, Inc. | 12 | $175 |
| Regeneron Healthcare Solutions, Inc. | 7 | $120 |
| Incyte Corporation | 6 | $116 |
| Sun Pharmaceutical Industries Inc. | 5 | $89 |
| Janssen Biotech, Inc. | 2 | $88 |
| Galderma Laboratories, L.P. | 5 | $87 |
| Organon LLC | 9 | $71 |
| Lilly USA, LLC | 4 | $69 |
Products named: SKYRIZI, Bimzelx, COSENTYX, OPZELURA, DUPIXENT, TREMFYA, RINVOQ, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
